max)均為1.5 h,平均消除半衰期(t1/2ke)為(2.9±0.8)h;峰濃度(Cmax)均值為(297.0±43.3)ng/mL;平均清除率(CL)為(0.373±0.116)mL/(h·kg);藥時曲線下面積(AUC0~24h)均值為(1 165±333)ng·h/mL。結論:血清樣品經(jīng) 5倍稀釋后用ELISA方法能較準確測定獼猴血清中rh-Tα1的量。6只獼猴sc rh-Tα1后達峰時間一致且較短,主要藥動學參數(shù)顯示一定個體差異,但無明顯性別差異。;Objective: To explore pharmacokinetic properties of a recombinant human Thymosin α1 (rh-Tα1) followingsc administration in monkeys. Methods: The monkeys received single sc doses of rh-Tα1 at 350 μg/kg. Serum concentration of rh-Tα1 was measured at various time-points after dosing by an enzyme-linked immunosorbent assay (ELISA). Pharmacokinetic parameters were calculated with 3P97 software. Results: The concentration-time profile of rh-Tα1 in monkeys was described by an one-compartment model. The mean time to reach peak concentration (tmax) was 1.5 h. The mean elimination half-life (t1/2ke) was (2.9 ± 0.8) h. The average clearance rate was (0.373 ± 0.116) mL/(h·kg). The mean peak concentration (Cmax) was (297.0 ± 43.3)ng/mL. The mean area under the serum concentration-time curve (AUC0~24 h) was (1 165 ± 333) ng·h/mL. Conclusion: Serum concentration of rh-Tα1 is detected accurately by ELISA method when serum samples are diluted five times. The tmax of the six monkeys are the same, but the main pharmacokinetic parameters demonstrate a certain degree of individual differences without obvious sex differences."/>